The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Transcatheter mitral valve repair with MitraClip in a large real-world experience: lessons from Germany

EuroIntervention 2019;14:1716-1719. DOI: 10.4244/EIJV14I17A296

1. Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA; 2. Division of Cardiology, Department of Medicine, University of Cape Town, Cape Town, South Africa; 3. Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy

Mitral regurgitation (MR) is the most common valvular heart disease in the Western world. Nearly one in 10 people aged ≥75 years is estimated to have moderate or severe MR1. However, ≈50% of patients with severe MR with an indication for surgery are turned down due to increased perioperative risk owing to advanced age, frailty, left ventricular dysfunction, and comorbidities2. This unmet need has led to the development of several percutaneous mitral valve repair and replacement technologies over the last decade3. Among the different devices available, the MitraClip® (Abbott Vascular, Santa Clara, CA, USA) repair system has become the most widely used. ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Nice, France, 20-21 June 2018